It’s not a secret that our prescription drug pricing system is broken. To address the root of the problem, the Biden administration recently convened a listening session seeking insights from experts on substantive solutions to improve patient access and affordability. Rightly so, the session focused primarily on the adverse effects of restrictive policies implemented by […]
Author Archives: David Balto
David Balto is a former policy director of the Federal Trade Commission and a public interest antitrust attorney. He wrote this for InsideSources.com.
